Related Experiment Video
Updated: Sep 24, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
[The effect of hemosorption repeated three times on activity of lecithin cholesterol acyltransferase]
Insights
Hemosorption therapy stabilized the lecithine-cholesterol acyltransferase (LCAT) system in atherosclerosis patients. This enzyme
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Medical Technology
Abstract:
Activity of lecithine-cholesterol acyltransferase (LCAT) was studied in blood of 26 patients with atherosclerosis of various localization after course of treatment involving three-fold hemosorption. The initial activity of the enzyme, decreased distinctly as compared with normal state, was dissimilarly altered during hemosorption. The system LCAT-HDLP was stabilized after the third hemosorption. These results relevant to programming hemosorption therapy of patients with atherosclerosis.

